Aktis Oncology, Inc. Common stock Cash Flow Reinvestment Rate
Aktis Oncology, Inc. Common stock cash flow reinvestment rate. Aktis Oncology, Inc. Common stock (AKTS) has a Cash Flow Reinvestment Rate of 12.90x as of December 2024, reinvesting $190.40 Million (capex $2.86 Million plus investments $-187.54 Million) from operating cash flow of $14.76 Million. Explore Aktis Oncology, Inc. Common stock (AKTS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aktis Oncology, Inc. Common stock (2024–2024)
Cash flow reinvestment rate of Aktis Oncology, Inc. Common stock from 2024 to 2024. Historical reinvestment intensity for Aktis Oncology, Inc. Common stock across 1 annual periods. Explore Aktis Oncology, Inc. Common stock capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Aktis Oncology, Inc. Common stock Cash Flow Reinvestment Rate by Year (2024–2024)
Aktis Oncology, Inc. Common stock cash flow reinvestment rate by year from 2024 to 2024. Year-by-year capital reinvestment analysis for Aktis Oncology, Inc. Common stock. For the full cash flow conversion analysis, see Aktis Oncology, Inc. Common stock operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 12.90x | $190.40 Million | $14.76 Million | $2.86 Million | — |